Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 11 trials

Late-Stage Pipeline

18%

2 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

7Total
Not Applicable (4)
Early P 1 (1)
P 3 (1)
P 4 (1)

Trial Status

Not Yet Recruiting4
Recruiting3
Active Not Recruiting2
Unknown1
Enrolling By Invitation1

Clinical Trials (11)

Showing 11 of 11 trials
NCT07465822Active Not Recruiting

The Learning Curve of a Gynecology and Obstetrics Resident Performing Vaginal Natural Orifice Transluminal Endoscopic Surgery (V-NOTES) Hysterectomy in a University Hospital

NCT07478614RecruitingPrimary

Multicenter Observational Cohort Study on the Epidemiology of Therapeutic Strategies in Patients Affected by Adenomyosis

NCT07120945Not ApplicableRecruiting

Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology)

NCT07397715RecruitingPrimary

Association of Ultrasound Features of the Myometrium Suggestive of Adenomyosis and Clinical Symptoms

NCT07335432Not ApplicableEnrolling By Invitation

RCT - Efficacy of Intravenous Vitamin C Versus Placebo on Estimated Blood Loss in Total Abdominal Hysterectomy

NCT07162961Phase 3Not Yet RecruitingPrimary

Nintedanib for Improving Reproductive Outcomes in Adenomyosis

NCT07065539Not ApplicableNot Yet RecruitingPrimary

GnRH Agonist Pretreatment Duration and Letrozole Supplementation in Frozen Embryo Transfer for Adenomyosis Patients

NCT06985186Phase 4Not Yet RecruitingPrimary

Does The Addition Of Letrozole To Ultra-Long GnRH Agonists Help Adenomyosis Patients in ART? The AURA Trial

NCT06765512Active Not RecruitingPrimary

Artificial Intelligence-Based Machine Learning to Diagnose and Classify Adenomyosis from Ultrasound Scans: a Multicentre Model Development Study

NCT06751264Not ApplicableNot Yet RecruitingPrimary

Evaluation of the Efficacy and Safety of Microwave Ablation of Uterine Adenomyosis Under Improved Ultrasound Guidance

NCT04535804Early Phase 1UnknownPrimary

Aspirin in the Treatment of Pregnant Women With Adenomyosis on Reducing Preterm Delivery

Showing all 11 trials

Research Network

Activity Timeline